PluriStem

Pluristem Therapeutics is an Israeli company engaged in the development of human placental adherent stromal cells for commercial use in disease treatment.[2] According to the company's website, it extracts adult stem cells exclusively from postnatal placentas.[3] Contents 1 Corporate history 2 Products 3 Human applications 4 See also 5 References 6 External links Corporate history Pluristem was founded in 2001 by Shai Meretzki of the Technion, who made u... [wikipedia]